Western Blot – IgG
<<Return to Search ResultsRequisition Forms
Reference Details
Detection of IgG antibodies to whole antigens plus recombinant VlsE of Borrelia burgdorferi sensu stricto (North American strain) by Western blot assay.
- Lyme Disease
Fresh human serum. Minimum volume of serum required – 0.5 mL.
Collect blood in serum separator tubes.
Transfer an aliquot of serum to a 1.5 ml screw-top vial with O-ring (Sarstedt vial). Store specimens refrigerated up to 5 days or store frozen until shipped for testing. Ship frozen on dry or wet ice.
Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.
Appropriate clinical symptoms with potential exposure to blacklegged ticks.
The IgG Western blot is intended for use in testing only human serum samples which have been found positive or equivocal by the ELISA procedure to provide supportive evidence of infection with B. burgdorferi.
Completed requisition for Tick-borne Disease Diagnostic Testing. If possible, include the clinical history and lab results performed at local or provincial laboratories.
Specimens may be subject to rejection if they are not the appropriate sample type, have insufficient volume, or are not accompanied by relevant patient information.
Commercial Western blot assay. This is a qualitative test for the detection of IgG antibody to individual proteins of B. burgdorferi. If early Borreliosis is suspected, serologic evidence of infection is best obtained by testing paired acute and convalescent phase serum samples collected 3 – 6 weeks apart.
Initiation of antibiotic treatment prior to testing may result in decreased antibody production which will affect the outcome of serological testing. However, if Lyme disease is suspected based on clinical symptoms, treatment should be initiated.
20 calendar days.
- Wormser, G.P., Dattwyler, R.J., Shapiro, E.D., et al. 2006. The clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious disease society of America. Clin. Inf. Dis. 43:1089-134.